Opko Health Inc. (AMEX:OPK) was downgraded by equities researchers at J P Morgan Chase & Co from an “overweight” rating to a “neutral” rating in a research note issued on Thursday.

Separately, Jefferies Group LLC restated a “hold” rating and issued a $8.00 price target on shares of Opko Health in a research note on Tuesday, June 13th.

Opko Health (AMEX:OPK) traded down 8.733% on Thursday, hitting $5.905. The stock had a trading volume of 13,631,049 shares. Opko Health has a 52-week low of $5.85 and a 52-week high of $12.15. The company’s market cap is $3.30 billion. The firm’s 50-day moving average is $6.23 and its 200-day moving average is $6.91.

COPYRIGHT VIOLATION NOTICE: This report was posted by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The original version of this report can be read at https://www.dailypolitical.com/2017/09/14/opko-health-inc-opk-cut-to-neutral-at-j-p-morgan-chase-co.html.

About Opko Health

OPKO Health, Inc is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations.

Receive News & Ratings for Opko Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.